Valuation: Ovation Science Inc.

Market Cap 1.15M 812K 715K 678K 612K 77.89M 1.17M 8.11M 3.12M 39.82M 3.05M 2.98M 128M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 1.36M 961K 846K 802K 724K 92.13M 1.38M 9.59M 3.69M 47.1M 3.61M 3.53M 151M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.56%
Yield 2024 *
-
Yield 2025 -
1 day-79.67%
3 months-78.57%
6 months-64.62%
Current year-74.58%
Current year 0.01
Extreme 0.007
0.08
1 year 0.01
Extreme 0.007
0.08
3 years 0.01
Extreme 0.007
0.12
5 years 0
Extreme 0.0023
0.12
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 2023-10-29
Chief Executive Officer 77 2017-10-03
Director TitleAgeSince
Director/Board Member 77 2017-10-03
Director/Board Member 63 2017-10-03
Director/Board Member 86 2018-02-01
Change 5-day change 1-year change 3-year change Capi.($)
-79.67%-.--% - - 812K
-1.39%-0.61%-4.66%+0.90% 344B
-0.34%-0.28%+2.97%-3.62% 230B
-0.26%-1.57%-7.00%+1.68% 131B
-0.58%+0.21%+7.72%+21.69% 68.92B
0.00%+3.08%+19.92% - 46.32B
+0.82%-2.83%-24.77%-23.79% 45.64B
-0.98%+0.48%+9.40%-12.62% 34.4B
-0.33%-4.74%+6.84%-34.34% 34.14B
-1.11%+0.35%-21.15%-17.62% 32.92B
Average -8.35%-1.28%-1.19%-8.47% 107.53B
Weighted average by Cap. -0.66%-1.07%-1.71%-2.26%

Financials

2024 2025
Net sales 113K 79.75K 70.23K 66.54K 60.07K 7.65M 115K 796K 306K 3.91M 299K 293K 12.53M 67.89K 47.82K 42.11K 39.9K 36.02K 4.59M 68.76K 477K 184K 2.34M 180K 176K 7.51M
Net income -456K -321K -283K -268K -242K -30.81M -462K -3.21M -1.23M -15.75M -1.21M -1.18M -50.5M -631K -445K -392K -371K -335K -42.63M -639K -4.44M -1.71M -21.8M -1.67M -1.63M -69.88M
Net Debt 265K 187K 164K 156K 141K 17.91M 269K 1.86M 718K 9.16M 701K 686K 29.35M 211K 148K 131K 124K 112K 14.24M 213K 1.48M 570K 7.28M 557K 545K 23.33M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-